Jun 17, 2020
CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
Jun 16, 2020
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
Jun 09, 2020
Twist Bioscience Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates
Jun 08, 2020
Intravacc and Versatope Sign Research Service Agreement to Develop Universal Influenza Vaccine Based on OMV technology
Jun 03, 2020
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
Jun 03, 2020
Novavax Selects AGC Biologics to Manufacture Matrix-M(TM) Adjuvant for Novel COVID-19 Vaccine
Jun 02, 2020
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
May 11, 2020
Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
Apr 30, 2020
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody(TM) Platform
Apr 24, 2020
Hoth Therapeutics, Inc., Voltron Therapeutics, Inc., & HaloVax Announce Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
Apr 23, 2020
ReiThera, LEUKOCARE and Univercells Announce Pan-European Consortium for the Fast-track Development of a Single-dose Adenovirus-based COVID-19 Vaccine
Apr 20, 2020
NanoPass Is Joining Forces With Pharma Partners in the Fight Against the COVID-19 Pandemic
Apr 09, 2020
Axon Neuroscience Has a Promising Peptide Vaccine Against COVID-19 in Development
Apr 02, 2020
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
Mar 26, 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Mar 24, 2020
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
Mar 17, 2020
PharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices
Mar 04, 2020
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
Feb 18, 2020
Phosplatin Therapeutics Announces Publication in OncoImmunology
Jan 15, 2020
INTELLiSTEM Announces the Launch of a New Antigen Identification Platform for the Development of Novel Car T Cells